These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35449452)

  • 1. Lipophagy-ICAM-1 pathway associated with fatty acid and oxygen deficiencies is involved in poor prognoses of ovarian clear cell carcinoma.
    Koizume S; Takahashi T; Nakamura Y; Yoshihara M; Ota Y; Sato S; Tadokoro H; Yokose T; Kato H; Miyagi E; Miyagi Y
    Br J Cancer; 2022 Aug; 127(3):462-473. PubMed ID: 35449452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid starvation and hypoxia synergistically activate ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancer.
    Koizume S; Ito S; Nakamura Y; Yoshihara M; Furuya M; Yamada R; Miyagi E; Hirahara F; Takano Y; Miyagi Y
    Mol Cancer; 2015 Apr; 14():77. PubMed ID: 25879517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray.
    Wang S; Yin C; Zhang Y; Zhang L; Tao L; Liang W; Pang L; Fu R; Ding Y; Li F; Jia W
    Biomed Res Int; 2019; 2019():2867372. PubMed ID: 31312656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-apoptotic genes are synergistically activated in OVSAYO cells cultured under conditions of serum starvation and hypoxia.
    Koizume S; Miyagi Y
    Genom Data; 2015 Sep; 5():129-31. PubMed ID: 26484240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer cell-derived CD69 induced under lipid and oxygen starvation promotes ovarian cancer progression through fibronectin.
    Koizume S; Kanayama T; Kimura Y; Hirano H; Takahashi T; Ota Y; Miyazaki K; Yoshihara M; Nakamura Y; Yokose T; Kato H; Takenaka K; Sato S; Tadokoro H; Miyagi E; Miyagi Y
    Cancer Sci; 2023 Jun; 114(6):2485-2498. PubMed ID: 36854451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas.
    Miyamoto M; Takano M; Aoyama T; Soyama H; Yoshikawa T; Tsuda H; Furuya K
    J Gynecol Oncol; 2017 May; 28(3):e33. PubMed ID: 28382796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble intercellular adhesion molecule-1 (ICAM-1) is released into the serum and ascites of human ovarian carcinoma patients and in nude mice bearing tumour xenografts.
    Giavazzi R; Nicoletti MI; Chirivi RG; Hemingway I; Bernasconi S; Allavena P; Gearing AJ
    Eur J Cancer; 1994; 30A(12):1865-70. PubMed ID: 7880619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible Factor-1α Suppression in Ovarian Clear-cell Carcinoma Cells by Silibinin Administration.
    Miyazawa M; Yasuda M; Miyazawa M; Ogane N; Katoh T; Yano M; Hirasawa T; Mikami M; Ishimoto H
    Anticancer Res; 2020 Dec; 40(12):6791-6798. PubMed ID: 33288572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.
    Vilming Elgaaen B; Olstad OK; Haug KB; Brusletto B; Sandvik L; Staff AC; Gautvik KM; Davidson B
    BMC Cancer; 2014 Feb; 14():80. PubMed ID: 24512620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer.
    Spowart JE; Townsend KN; Huwait H; Eshragh S; West NR; Ries JN; Kalloger S; Anglesio M; Gorski SM; Watson PH; Gilks CB; Huntsman DG; Lum JJ
    J Pathol; 2012 Dec; 228(4):437-47. PubMed ID: 22926683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol Starvation and Hypoxia Activate the FVII Gene via the SREBP1-GILZ Pathway in Ovarian Cancer Cells to Produce Procoagulant Microvesicles.
    Koizume S; Takahashi T; Yoshihara M; Nakamura Y; Ruf W; Takenaka K; Miyagi E; Miyagi Y
    Thromb Haemost; 2019 Jul; 119(7):1058-1071. PubMed ID: 31055798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.
    Yanaihara N; Hirata Y; Yamaguchi N; Noguchi Y; Saito M; Nagata C; Takakura S; Yamada K; Okamoto A
    Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis.
    Ayhan A; Kuhn E; Wu RC; Ogawa H; Bahadirli-Talbott A; Mao TL; Sugimura H; Shih IM; Wang TL
    Mod Pathol; 2017 Feb; 30(2):297-303. PubMed ID: 27767100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between PI3K and Ras pathways via protein phosphatase 2A in human ovarian clear cell carcinoma.
    Takai M; Nakagawa T; Tanabe A; Terai Y; Ohmichi M; Asahi M
    Cancer Biol Ther; 2015; 16(2):325-35. PubMed ID: 25756515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells.
    Mogami T; Yokota N; Asai-Sato M; Yamada R; Koizume S; Sakuma Y; Yoshihara M; Nakamura Y; Takano Y; Hirahara F; Miyagi Y; Miyagi E
    PLoS One; 2013; 8(11):e80359. PubMed ID: 24244679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.
    Makii C; Oda K; Ikeda Y; Sone K; Hasegawa K; Uehara Y; Nishijima A; Asada K; Koso T; Fukuda T; Inaba K; Oki S; Machino H; Kojima M; Kashiyama T; Mori-Uchino M; Arimoto T; Wada-Hiraike O; Kawana K; Yano T; Fujiwara K; Aburatani H; Osuga Y; Fujii T
    Oncotarget; 2016 Nov; 7(46):75328-75338. PubMed ID: 27659536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction value of intercellular adhesion molecule-1 gene polymorphisms for epithelial ovarian cancer risk, clinical features, and prognosis.
    Cai G; Ma X; Zou W; Huang Y; Zhang J; Wang D; Chen B
    Gene; 2014 Aug; 546(1):117-23. PubMed ID: 23933413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF-kappaB independent pathway.
    Takizawa K; Kamijo R; Ito D; Hatori M; Sumitani K; Nagumo M
    Br J Cancer; 1999 Jun; 80(7):954-63. PubMed ID: 10362102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma.
    Lee S; Garner EI; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2007 Aug; 106(2):311-7. PubMed ID: 17532031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas.
    Arnold JM; Cummings M; Purdie D; Chenevix-Trench G
    Br J Cancer; 2001 Nov; 85(9):1351-8. PubMed ID: 11720474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.